usa S, Malato A, Saccullo G, Iorio A, Di Ianni M, Caracciolo C,
et al. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower
limbs: The extended DACUS study. Am J Hematol 2011;86:914-7.
539. Carrier M, Rodger MA, Wells PS, Righini M, Le Gal G. Residual vein
obstruction to predict the risk of recurrent venous thromboembolism
in patients with deep vein thrombosis: A systematic review and metaanalysis. J Thromb Haemost 2011;9:1119-25.
540. Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W,
et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein
thrombosis (the CaVenT study): A randomised controlled trial.
Lancet 2012;379:31-8.
541. Popuri RK, Vedantham S. The role of thrombolysis in the clinical
management of deep vein thrombosis. Arterioscler Thromb Vasc Biol
2011;31:479-84.
542. Abu-Own A, Scurr JH, Coleridge Smith PD. Effect of leg elevation
on the skin microcirculation in chronic venous insufÔ¨Åciency. J Vasc
Surg 1994;20:705-10.
543. Yang D, Vandongen YK, Stacey MC. Effect of exercise on calf muscle
pump function in patients with chronic venous disease. Br J Surg
1999;86:338-41.
544. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM,
Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline
(2006 revision). J Foot Ankle Surg 2006;45:S1